{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:03:45Z","timestamp":1775819025457,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["Universit\u00e0 degli Studi di Ferrara"],"award-info":[{"award-number":["Universit\u00e0 degli Studi di Ferrara"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["Universit\u00e0 degli Studi di Ferrara"],"award-info":[{"award-number":["Universit\u00e0 degli Studi di Ferrara"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"publisher","award":["Universit\u00e0 degli Studi di Ferrara"],"award-info":[{"award-number":["Universit\u00e0 degli Studi di Ferrara"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010662","name":"H2020 Excellent Science","doi-asserted-by":"publisher","award":["E93C22001080001"],"award-info":[{"award-number":["E93C22001080001"]}],"id":[{"id":"10.13039\/100010662","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Familial Dysautonomia (FD, OMIM #223900) is a rare, life-threatening autosomal recessive neuropathy caused in 99.8% of patients by the c.2204\u2009+\u20096T\u2009&gt;\u2009C intronic mutation in the\n                    <jats:italic>ELP1\/IKAP<\/jats:italic>\n                    gene. This substitution induces exon 20 skipping, leading to reduced ELP1 expression. While splicing-modulating therapies have shown partial efficacy, a permanent genetic correction remains unavailable. Here, we report the first application of Prime Editing (PE) to rescue the FD-causing\n                    <jats:italic>IKAP<\/jats:italic>\n                    splicing defect. Using a mutant exon-trapping minigene (pTB-\n                    <jats:italic>IKAP<\/jats:italic>\n                    ) transiently co-transfected in HEK293T cells with PE2 or PE3 components, we demonstrate a significant increase in exon 20 inclusion, from 19\u2009\u00b1\u20092% to 48\u2009\u00b1\u20093% and 60\u2009\u00b1\u20093%, respectively. Restriction fragment length polymorphism and Sanger sequencing confirmed correction of the mutant allele, with PE3 achieving\u2009~\u200910% genomic editing efficiency. Moreover, by targeting ESS2 via a silent A\u2009&gt;\u2009G substitution, we similarly restored exon inclusion to 50\u2009\u00b1\u20094%. These findings provide proof-of-principle that prime editing, particularly PE3, can efficiently correct or bypass the\n                    <jats:italic>ELP1\/IKAP<\/jats:italic>\n                    c.2204\u2009+\u20096T\u2009&gt;\u2009C mutation and restore proper splicing. Given that modest increases in ELP1 expression (5\u201310% of wild-type) markedly alleviate FD severity in mouse models, our results highlight PE as a promising, potentially curative approach and lay the foundation for future ex-vivo and in vivo studies.\n                  <\/jats:p>","DOI":"10.1186\/s13023-026-04292-8","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:07:08Z","timestamp":1775815628000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prime editing of the common Familial Dysautonomia-causing c.2204\u2009+\u20096T\u2009&gt;\u2009C splicing mutation"],"prefix":"10.1186","volume":"21","author":[{"given":"Laura","family":"Peretto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirko","family":"Pinotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6675-9429","authenticated-orcid":false,"given":"Dario","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"4292_CR1","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.pneurobio.2016.06.003","volume":"152","author":"L Norcliffe-Kaufmann","year":"2017","unstructured":"Norcliffe-Kaufmann L, Slaugenhaupt SA, Kaufmann H. Familial dysautonomia: History, genotype, phenotype and translational research. Prog Neurobiol. 2017;152:131\u201348.","journal-title":"Prog Neurobiol"},{"issue":"12","key":"4292_CR2","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1242\/dev.107797","volume":"141","author":"MZ Jackson","year":"2014","unstructured":"Jackson MZ, Gruner KA, Qin C, Tourtellotte WG. A neuron autonomous role for the familial dysautonomia gene ELP1 in sympathetic and sensory target tissue innervation. Development. 2014;141(12):2452\u201361.","journal-title":"Development"},{"issue":"3","key":"4292_CR3","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1086\/318808","volume":"68","author":"SL Anderson","year":"2001","unstructured":"Anderson SL, Coli R, Daly IW, Kichula EA, Rork MJ, Volpi SA, et al. Familial dysautonomia is caused by mutations of the IKAP gene. Am J Hum Genet. 2001;68(3):753\u20138.","journal-title":"Am J Hum Genet"},{"issue":"3","key":"4292_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1086\/318810","volume":"68","author":"SA Slaugenhaupt","year":"2001","unstructured":"Slaugenhaupt SA, Blumenfeld A, Gill SP, Leyne M, Mull J, Cuajungco MP, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet. 2001;68(3):598\u2013605.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"4292_CR5","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ng0693-160","volume":"4","author":"A Blumenfeld","year":"1993","unstructured":"Blumenfeld A, Slaugenhaupt SA, Axelrod FB, Lucente DE, Maayan C, Liebert CB, et al. Localization of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet. 1993;4(2):160\u20134.","journal-title":"Nat Genet"},{"issue":"12","key":"4292_CR6","doi-asserted-by":"publisher","first-page":"e15590","DOI":"10.1371\/journal.pone.0015590","volume":"5","author":"N Boone","year":"2010","unstructured":"Boone N, Loriod B, Bergon A, Sbai O, Formisano-Tr\u00e9ziny C, Gabert J, et al. Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia. PLoS ONE. 2010;5(12):e15590.","journal-title":"PLoS ONE"},{"issue":"15","key":"4292_CR7","doi-asserted-by":"publisher","first-page":"7938","DOI":"10.1093\/nar\/gky395","volume":"46","author":"GH Bruun","year":"2018","unstructured":"Bruun GH, Bang JMV, Christensen LL, Br\u00f8ner S, Petersen USS, Guerra B, et al. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells. Nucleic Acids Res. 2018;46(15):7938\u201352.","journal-title":"Nucleic Acids Res"},{"issue":"23","key":"4292_CR8","doi-asserted-by":"publisher","first-page":"5078","DOI":"10.1093\/hmg\/dds354","volume":"21","author":"P Dietrich","year":"2012","unstructured":"Dietrich P, Alli S, Shanmugasundaram R, Dragatsis I. IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia. Hum Mol Genet. 2012;21(23):5078\u201390.","journal-title":"Hum Mol Genet"},{"issue":"8","key":"4292_CR9","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.ajhg.2022.07.004","volume":"109","author":"G Romano","year":"2022","unstructured":"Romano G, Riccardi F, Bussani E, Vodret S, Licastro D, Ragone I, et al. Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA. Am J Hum Genet. 2022;109(8):1534\u201348.","journal-title":"Am J Hum Genet"},{"issue":"14","key":"4292_CR10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/hmg\/ddy151","volume":"27","author":"I Donadon","year":"2018","unstructured":"Donadon I, Pinotti M, Rajkowska K, Pianigiani G, Barbon E, Morini E, et al. Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model. Hum Mol Genet. 2018;27(14):2466\u201376.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"4292_CR11","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1093\/nar\/gky249","volume":"46","author":"R Sinha","year":"2018","unstructured":"Sinha R, Kim YJ, Nomakuchi T, Sahashi K, Hua Y, Rigo F, et al. Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice. Nucleic Acids Res. 2018;46(10):4833\u201344.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4292_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1080\/14737175.2025.2525400","volume":"25","author":"M Grobocopatel Marra","year":"2025","unstructured":"Grobocopatel Marra M, Kuijpers M, Kaufmann H, Gonzalez-Duarte A. Advances in the treatment of familial dysautonomia: what does the future hold? Expert Rev Neurother. 2025;25(8):939\u201349.","journal-title":"Expert Rev Neurother"},{"issue":"9","key":"4292_CR13","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.molmed.2025.01.015","volume":"31","author":"O Devinsky","year":"2025","unstructured":"Devinsky O, Coller J, Ahrens-Nicklas R, Liu XS, Ahituv N, Davidson BL, et al. Gene therapies for neurogenetic disorders. Trends Mol Med. 2025;31(9):814\u201326.","journal-title":"Trends Mol Med"},{"issue":"7785","key":"4292_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","volume":"576","author":"AV Anzalone","year":"2019","unstructured":"Anzalone AV, Randolph PB, Davis JR, Sousa AA, Koblan LW, Levy JM, et al. Search-and-replace genome editing without double-strand breaks or donor DNA. Nature. 2019;576(7785):149\u201357.","journal-title":"Nature"},{"issue":"22","key":"4292_CR15","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1016\/j.cell.2021.09.018","volume":"184","author":"PJ Chen","year":"2021","unstructured":"Chen PJ, Hussmann JA, Yan J, Knipping F, Ravisankar P, Chen PF, et al. Enhanced prime editing systems by manipulating cellular determinants of editing outcomes. Cell. 2021;184(22):5635\u2013e565229.","journal-title":"Cell"},{"issue":"8","key":"4292_CR16","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/s41587-022-01613-7","volume":"41","author":"N Mathis","year":"2023","unstructured":"Mathis N, Allam A, Kissling L, Marquart KF, Schmidheini L, Solari C, et al. Predicting prime editing efficiency and product purity by deep learning. Nat Biotechnol. 2023;41(8):1151\u20139.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"4292_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s12276-025-01463-8","volume":"57","author":"J Lee","year":"2025","unstructured":"Lee J, Kweon J, Kim Y. Emerging trends in prime editing for precision genome editing. Exp Mol Med. 2025;57(7):1381\u201391.","journal-title":"Exp Mol Med"},{"key":"4292_CR18","doi-asserted-by":"crossref","unstructured":"Nelson JW, Randolph PB, Shen SP, Everette KA, Chen PJ, Anzalone AV, et al. Engineered pegRNAs improve prime editing efficiency. Nat Biotechnol. 2022;40(3):402\u201310.","DOI":"10.1038\/s41587-021-01039-7"},{"issue":"411","key":"4292_CR19","doi-asserted-by":"publisher","first-page":"eaan0820","DOI":"10.1126\/scitranslmed.aan0820","volume":"9","author":"G Schiroli","year":"2017","unstructured":"Schiroli G, Ferrari S, Conway A, Jacob A, Capo V, Albano L, et al. Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1. Sci Transl Med. 2017;9(411):eaan0820.","journal-title":"Sci Transl Med"},{"issue":"3","key":"4292_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jamaneurol.2023.4983","volume":"81","author":"SE Salomonsson","year":"2024","unstructured":"Salomonsson SE, Clelland CD. Building CRISPR Gene Therapies for the Central Nervous System: A Review. JAMA Neurol. 2024;81(3):283\u201390.","journal-title":"JAMA Neurol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-026-04292-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-026-04292-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:07:10Z","timestamp":1775815630000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-026-04292-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1186\/s13023-026-04292-8","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"144"}}